RAS G12C Inhibitors: Three Birds with One Stone.

Abstract excerpt

SUMMARY: In this issue, Rubinson, Tanaka, and colleagues demonstrate that differences among G12C inhibitors rely on their ability to covalently bind not only G12C mutant KRAS but also NRAS and HRAS, proposing sotorasib as a potent NRAS G12C inhibitor. See related article by Rubinson et al., p. 727 (6).

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Mutation
• Share to Piperazines
• Share to Antineoplastic Agents